Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 1, 2011, Pages 23-32

  Thatipamula, R P ^a   Palem, C R ^a   Gannu, R ^a   Mudragada, S ^a   Yamsani, M R ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

DSC; Entrapment efficiency; Polydispersity index; TEM

Indexed keywords

DOMPERIDONE; LIPID; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; SURFACTANT; TRIACYLGLYCEROL; TRIMYRISTIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISPERSION; IN VITRO STUDY; MATERIAL STATE; MOLECULAR IMAGING; NANOANALYSIS; NANOFABRICATION; NANOPHARMACEUTICS; PARTICLE SIZE; PROCESS OPTIMIZATION; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND; ZETA POTENTIAL;

EID: 79953290173     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm, 2000; 50:161-177.
2. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nano structured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev, 2002b; 54:S131-S155.
3. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv.Rev, 2001; 47:165-196.
4. Müller RH, MaaBen S, Weyhers H, Specht F, Lucks JS. Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles (SLN). Int. J. Pharm, 1996a; 138:85-94.
5. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Rel, 1999; 59:299-307.
6. Liu J, Zhu J, Du & Bin Qin Z. Preparation and Pharmacokinetic Evaluation of Tashinone IIA Solid Lipid Nanoparticles. Drug Dev. Ind. Pharm, 2005; 31:551-556.
7. Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Xiuzhen H. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int. J. Pharm, 2006; 327:153-159.
8. Bhaskar K, Krishna Mohan C, Lingam M, Jagan Mohan S, Venkateswarlu V, Madhusudan Rao Y, Jayaraman A, Ravichandran V. Development of SLN and NLC Enriched Hydrogels for Transdermal Delivery of Nitrendipine: In Vitro and In Vivo Characteristics. Drug Dev. Ind. Pharm, 2008; 34: 719-725.
9. Yang S, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control Rel, 1999; 59:299-307.
10. Cavalli R, Alessandro B, Valerio P, Muntoni E, Zara G, Gaseo MR. Duodenal Administration of Solid Lipid Nanoparticles Loaded with Different Percentages of Tobramycin. J. Pharm. Sei, 2003; 92: 1085-1094.
11. Luo Y Chen D, Ren L, Zhao X, Jing Q. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control Rel, 2006; 114:53-59.
12. Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int. J. Pharm, 2008; 348:137-145.
13. Jores K, Mehenert W, Mader K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles. A nuclear magnetic resonance study, 2003; 20:1274-1283.
14. Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid Nanoparticles - Evaluation of the method and process parameters. Eur. J. Pharm Biopharm, 2003; 55: 125-131.
15. Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J. Control. Rel, 2005; 108:112-120.
16. Sweetman SC. Martindale-The complete drug reference. Pharmaceutical Press, London. (U.K), 2007; 1556- 1557.
17. Madishetti SK, Palem CR, Gannu R, Thatipamula RP, Panakanti PK, Yamsani MR. Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization. DARU, 2010; 18:221-229.
18. Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Rel, 2004; 95:627-638.
19. Radtke M, Eliana Souto B, Muller RH, Nanostructured Lipid Carriers: ANovel Generation of Solid Lipid Drug Carriers. Pharm. Tech. Europe, 2005; 17:45-50.
20. Westesen K, Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int. J. Pharm, 1995; 115:129-131.
21. Staggers JE, Hernell O, Stafford RJ, Carey MC. Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption, I: phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry, 1990; 29:2028-2040.